Increased mRNA in NK cells from CFS/ME patients has been demonstrated [13], supported by an increase in circulating IFN-γ secreting CD3- CD56+ NK cells described in CFS/ME patients [78]. This evidence concerns the gene NCAM1 and myalgic encephalomeyelitis/chronic fatigue syndrome.